Reviews from the Academic Research Consortium 3 – Coronary Interventions
Published: 08 November 2023
The Academic Research Consortium (ARC) is an international collaborative forum across medical device stakeholders that includes academics, clinical trialists, regulatory bodies and industry.
The purpose of the ARC is to create a dynamic, transparent and collaborative forum for stakeholders to develop consensus definitions and standard nomenclature in pivotal clinical trials of medical devices and to disseminate such definitions and recommended processes into the public domain.
The ARC-2 initiative (2018) updated the widely used ARC-1 pragmatic consensus definitions for coronary device trials (2007) to incorporate experience gained with the initial definitions, interim recommendations from professional societies, and the expansion of clinical trials to include more complex patient/lesion subsets and novel devices. Coronary research definitions continue to evolve and the ARC-3 initiative is ongoing.
This webinar series addresses the hot topics in interventional cardiology, providing state-of-the-art reviews by global leaders from all over the world. Presentations were prepared for the ARC-3 in-person meeting earlier in 2023 and deal with historical and future perspectives.
Learn more about ARC at: www.academicresearchconsortium.org
Key Learning Objectives
- Discover the existing data, unmet needs, and practical considerations about personalisation of revascularization strategies, either through coronary artery bypass grafting or percutaneous coronary interventions
- Witness the unprecedented evolution of wire-based physiology, angio-based physiology, and CT-based physiology, for assessment of the severity and clinical relevance of coronary stenosis
- Explore the strength of coronary imaging data based on ongoing and completed studies in America, Asia, and Europe
- Learn about the largest studies in coronary physiology and coronary imaging that will determine the future indication and recommendation classes in clinical practice guideline
- Immerse into the possibilities of registry-based research through the eyes of some of the most notable experts on this topic globally
- Interventional Cardiologists
More from this programme
State-of-The-Art in Coronary Research: Imaging Trials
State-of-The-Art in Coronary Research: Physiology Trials
State-of-The-Art in Registry-based Research: Imaging and Physiology
State-of-The-Art in Coronary Research: CABG vs. PCI Trials
Hector M Garcia-Garcia
Dr Hector Garcia-Garcia is director of angiographic, intravascular ultrasound, optical coherence tomography and near infrared spectroscopy imaging at the Cardiovascular Core Laboratory, MedStar Cardiovascular Research Network, MedStar Washington Hospital Center (MWHC). He is also chairman of the Clinical Event committee and an attending cardiologist at MedStar Heart and Vascular Institute, MWHC.
Prior to joining MedStar, he served as director of the core invasive imaging laboratory at a clinical research organisation and as a researcher at the Erasmus Medical Center, Rotterdam. He obtained his degree from the Universidad Autónoma de Guadalajara, Mexico. He completed a residency in cardiology and a fellowship in interventional cardiology at the Instituto Nacional de Cardiologia Ignacio Chavez and the Universidad Nacional Autónoma de Mexico. His master’s degree in epidemiology and his doctorate degree in clinical research are from the Erasmus University Rotterdam, the…
Dr Shao-Liang Chen is an interventional cardiologist at the Nanjing First Hospital, Nanjing Medical University, Jiangsu Province, Nanjing, China. Dr Chen has published over 300 papers in peer-reviewed journals.
Dr Chen's research interests include coronary intervention, pulmonary arterial hypertension and biological molecular science.
Dr Shao-Liang Chen is Section Editor of European Cardiology Review.